Safety in Immunomodulatory Functions of Campath-1H (PC01)
收藏DataCite Commons2022-12-21 更新2025-04-16 收录
下载链接：
https://www.immport.org/shared/study/SDY134
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicenter, open label, single arm trial to evaluate the safety of alemtuzumab after kidney transplantation as part of a multitherapy regimen to prevent kidney graft loss and death and to avoid steroids and chronic use of calcineurin inhibitors in pediatric renal transplant recipients 1 to 20 years of age.
提供机构：
ImmPort
创建时间：
2016-11-01
